guest ::
| Home > Publications Database > Insomnia in neurological diseases. > print |
| 001 | 164189 | ||
| 005 | 20230915092429.0 | ||
| 024 | 7 | _ | |a 10.1186/s42466-021-00106-3 |2 doi |
| 024 | 7 | _ | |a pmid:33691803 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC7944611 |2 pmc |
| 024 | 7 | _ | |a altmetric:101678234 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-00845 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Mayer, Geert |b 0 |
| 245 | _ | _ | |a Insomnia in neurological diseases. |
| 260 | _ | _ | |a [London] |c 2021 |b BioMed Central |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1655112980_6961 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a (CC BY) |
| 520 | _ | _ | |a Insomnia is defined as difficulties of initiating and maintaining sleep, early awakening and poor subjective sleep quality despite adequate opportunity and circumstances for sleep with impairment of daytime performance. These components of insomnia - namely persistent sleep difficulties despite of adequate sleep opportunity resulting in daytime dysfunction - appear secondary or co-morbid to neurological diseases. Comorbid insomnia originates from neurodegenerative, inflammatory, traumatic or ischemic changes in sleep regulating brainstem and hypothalamic nuclei with consecutive changes of neurotransmitters. Symptoms of neurological disorders (i.e motor deficits), co-morbidities (i.e. pain, depression, anxiety) and some disease-specific pharmaceuticals may cause insomnia and/or other sleep problems.This guideline focuses on insomnias in headaches, neurodegenerative movement disorders, multiple sclerosis, traumatic brain injury, epilepsies, stroke, neuromuscular disease and dementia.The most important new recommendations are: Cognitive behavioral therapy (CBTi) is recommended to treat acute and chronic insomnia in headache patients. Insomnia is one of the most frequent sleep complaints in neurodegenerative movement disorders. Patients may benefit from CBTi, antidepressants (trazodone, doxepin), melatonin and gaba-agonists. Insomnia is a frequent precursor of MS symptoms by up to 10 years. CBTi is recommended in patients with MS, traumatic brain injury and. Melatonin may improve insomnia symptoms in children with epilepsies. Patients with insomnia after stroke can be treated with benzodiazepine receptor agonists and sedating antidepressants. For patients with dementia suffering from insomnia trazodone, light therapy and physical exercise are recommended. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Classifications |2 Other |
| 650 | _ | 7 | |a Cognitive behavioral therapy |2 Other |
| 650 | _ | 7 | |a Comorbid diseases |2 Other |
| 650 | _ | 7 | |a Diagnostic instruments |2 Other |
| 650 | _ | 7 | |a Insomnia |2 Other |
| 650 | _ | 7 | |a Neurological diseases |2 Other |
| 650 | _ | 7 | |a Therapeutic recommendations |2 Other |
| 700 | 1 | _ | |a Happe, Svenja |b 1 |
| 700 | 1 | _ | |a Evers, Stefan |b 2 |
| 700 | 1 | _ | |a Hermann, Wiebke |0 P:(DE-2719)2814194 |b 3 |u dzne |
| 700 | 1 | _ | |a Jansen, Sabine |b 4 |
| 700 | 1 | _ | |a Kallweit, Ulf |b 5 |
| 700 | 1 | _ | |a Muntean, Maria-Lucia |b 6 |
| 700 | 1 | _ | |a Pöhlau, Dieter |b 7 |
| 700 | 1 | _ | |a Riemann, Dieter |b 8 |
| 700 | 1 | _ | |a Saletu, Michael |b 9 |
| 700 | 1 | _ | |a Schichl, Melanie |b 10 |
| 700 | 1 | _ | |a Schmitt, Wolfgang J |b 11 |
| 700 | 1 | _ | |a Sixel-Döring, Friederike |b 12 |
| 700 | 1 | _ | |a Young, Peter |b 13 |
| 773 | _ | _ | |a 10.1186/s42466-021-00106-3 |g Vol. 3, no. 1, p. 15 |0 PERI:(DE-600)2947493-0 |n 1 |p 15 |t Neurological research and practice |v 3 |y 2021 |x 2524-3489 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/164189/files/DZNE-2022-00845.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/164189/files/DZNE-2022-00845.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:164189 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2814194 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2020-09-08 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2019-05-24T10:38:19Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2019-05-24T10:38:19Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2019-05-24T10:38:19Z |
| 920 | 1 | _ | |0 I:(DE-2719)1510100 |k AG Teipel |l Clinical Dementia Research Rostock /Greifswald |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1510100 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|